Management of Childhood Asthma with Shatyadi Churna
Phase 3
- Conditions
- Health Condition 1: J45- AsthmaHealth Condition 2: J454- Moderate persistent asthma
- Registration Number
- CTRI/2021/12/038922
- Lead Sponsor
- ITRA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Diagnosed cases of bronchial asthma
Patients having signs and symptoms of Tamaka Shwasa
Exclusion Criteria
Children of either sex belonging to age ground below 5 years and above 16yrs
Evidence of requirement for intubation or had been hospitalized within or before 1 month
unresolved sinus disease or an unresolved upper or lower respiratory tract infection within 4 weeks
Patients suffering from systemic illness such as TB HIV and other chronic debilitating disease
Evidence of active pulmonary disease other than asthma
Patients using any oral corticosteroids Astemizole Nedocromil Cromolyn and Long acting B agonist Ketotifen or Theophylline
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in the laboratory investigations for eg Hb TLC DLC ESR and AEC <br/ ><br>Improvement in peak flow meter and spirometry parameter <br/ ><br>Less frequency of Asthma attack and relief in dyspneaTimepoint: after 8 weeks
- Secondary Outcome Measures
Name Time Method Improvement in clinical signs and symptoms of Tamaka Shwasa for eg Ghurghurakam Kricchrashaknoti bhasitum KasaTimepoint: Day 0 and Day 56